Which blood biomarkers actually matter for longevity?

Short answer: several blood biomarkers strongly track risk of age‑related disease and all‑cause mortality. The most useful ones for “longevity” are those that reflect cardiometabolic risk, inflammation, organ function, nutrition, and biological aging. Below I list the high‑priority markers, why they matter, reasonable target directions, how to change them, testing cadence, and a few lab/consumer services you can use.

High‑priority blood biomarkers for longevity (what they mean and practical targets)

• Glycemic control

  • HbA1c: reflects average glucose. Why: higher HbA1c predicts diabetes, cardiovascular disease, and mortality. Target: ideally <5.7% (non‑diabetic range); keep as low as safely possible without hypoglycemia. Interventions: weight loss, Mediterranean/low‑refined‑carb eating patterns, exercise, sleep, and, if indicated, medications under a clinician’s guidance.
  • Fasting glucose / fasting insulin: fasting glucose <100 mg/dL; fasting insulin lower is generally better (fasting insulin <10 µIU/mL often used), because insulin resistance is a key aging driver.

• Atherogenic lipids & lipoproteins

  • ApoB (preferred) and LDL‑C, non‑HDL, triglycerides: Why: atherogenic particle number (ApoB) is strongly linked to cardiovascular mortality. Targets vary by risk—general longevity goal: ApoB <80 mg/dL (lower if high risk), LDL‑C often <100 mg/dL (or <70 mg/dL if high risk). TG <150 mg/dL.
  • Lp(a): genetically driven atherosclerotic risk; lower is better. Consider testing once (Lp(a) is mostly fixed by genetics). Thresholds: >50 mg/dL (≈125 nmol/L) indicates elevated risk.

• Inflammation

  • High‑sensitivity CRP (hs‑CRP): chronic inflammation predicts CVD and mortality. Target: <1 mg/L is low risk; >3 mg/L is high. Interventions: weight loss, exercise, smoking cessation, Mediterranean diet, treat infections/periodontal disease, consider statin therapy if indicated.
  • IL‑6 and other cytokines are informative in research/complex cases but not routine for most people.

• Kidney function

  • Serum creatinine with eGFR and cystatin C (if available): kidney function decline is a strong mortality predictor. Target: eGFR >60 mL/min/1.73m2; rising creatinine or cystatin C signals risk.

• Liver health

  • ALT, AST, GGT: elevated enzymes (especially GGT) are associated with metabolic dysfunction and mortality. Keep within normal range; investigate persistent elevations.

• Hematology & general reserves

  • Hemoglobin/hematocrit and albumin: anemia and low albumin are independently associated with worse outcomes in older adults. Keep hemoglobin in normal range for sex/age; albumin >3.5–4.0 g/dL.

• Nutritional markers

  • 25‑hydroxy vitamin D: low levels associate with worse outcomes. Target commonly 30–50 ng/mL (many clinicians aim ~30–50 or 40–60 for older adults).
  • Vitamin B12, folate, ferritin (iron stores): correct deficiencies (B12 especially in older adults).
  • Omega‑3 index (erythrocyte EPA+DHA): higher omega‑3 index correlates with lower cardiac mortality; measured by specialty labs—target often ≥8%.

• Coagulation / clotting risk

  • D‑dimer and fibrinogen sometimes predict risk in older adults; used in context.

• Hormones & growth factors (age/context dependent)

  • Testosterone/estradiol (when clinically indicated): low testosterone in men is associated with frailty; but hormone replacement is nuanced.
  • IGF‑1: linked to aging biology; extremes (very high or very low) can increase risk. Interpretation is complex—no universal target; consider in research/clinical contexts.

• Markers of biological age / epigenetic clocks (optional, emerging)

  • DNA methylation clocks (Horvath/GrimAge), telomere length, GlycanAge: these are evolving but can give an integrated measure of biological age. Use for tracking interventions rather than clinical decision‑making.

Practical testing frequency

• Healthy adult with no specific risks: annual basic panel (CMP, lipid panel, CBC, HbA1c, hs‑CRP, vitamin D/B12) is reasonable.
• If you have risk factors (family history, high BP, dyslipidemia, prediabetes), test more often (every 3–6 months while addressing abnormalities).
• Some tests are one‑time (Lp[a], genetic risk) unless changes are expected.

How to use these results

• Focus on modifiable drivers: smoking cessation, BP control, weight loss if overweight, physical activity (resistance + aerobic), Mediterranean/whole‑food diet, sleep, stress reduction, vaccination, and evidence‑based medications when clinically indicated (statins, antihypertensives, diabetes meds).
• Treat abnormalities in context—e.g., a mildly elevated CRP with obesity should prompt weight/fat loss and evaluation for infection/inflammatory conditions.

Caveats

• Associations vs causation: many biomarkers are risk correlates, not direct “aging clocks.” Interventions that change the biomarker are most valuable when they also reduce hard outcomes (heart attacks, strokes, disability).
• Targets vary by age, sex, comorbidities, and personal risk tolerance—discuss abnormal results with your clinician.
• Over‑testing and overtreatment can be harmful; prioritize actionable markers.

Recommended labs / services (short list and why)

• Quest Diagnostics and Labcorp — nationwide clinical labs that perform comprehensive panels (lipids, HbA1c, CMP, hs‑CRP, ApoB, Lp(a), cystatin C). Good for physician‑ordered tests and many DTC requisitions.
• OmegaQuant — specialized lab for the omega‑3 index (erythrocyte EPA+DHA), useful if you want a reliable omega‑3 biomarker.
• InsideTracker and WellnessFX — consumer services that combine lab testing with easily actionable recommendations and coaching. Good if you want interpretation and lifestyle guidance tailored to results.
• Everlywell and LetsGetChecked — at‑home testing kits for common markers (lipids, HbA1c, vitamin D, etc.). Convenient for screening but limited for complex testing.
• TruDiagnostic (or similar providers) — for DNA methylation (epigenetic) age testing. Useful if you want to track biological age as an experimental measure.

If you want, I can:

• Suggest a compact “longevity panel” you can order right now based on your age/sex/health history.
• Explain how to interpret any specific lab result you have (send values and reference ranges).